Bringing a Stand-Alone Immune Effector Cell Therapy Program into FACT Compliance Wednesday, August 26, 2020 August 26 at 11:00 AM ET Webinar

The registration period for this meeting has ended.

This presentation is Wednesday, August 26, 2020, at 11:00 am ET, 15:00 GMT.

Presenters will explain the rationale for FACT accreditation of immune effector cell programs, and compare and contrast immune effector cell therapy with other non-cell-based therapies. Presenters will also summarize the major concepts addressed in the FACT IEC Standards and how to plan a self-assessment against the FACT IEC Standards.

Presenters include:

Kris Michael Mahadeo MD, MPH
Associate Professor/Section Chief Pediatric SCT-CT
The University of Texas MD Anderson Cancer Center Stem Cell Transplantation and Cellular Therapy

Alison Gulbis, PharmD
The University of Texas MD Anderson Cancer Center Stem Cell Transplantation and Cellular Therapy

Registration Fees: These fees are available through 08/26/2020
Name	Price	Available To
Regular	$100.00	Workshop Registrants
Inspector Fee	$0.00	Inspectors and Inspector Trainees
Industry	$500.00	Industry Representatives